GMDAQ — Gamida Cell Share News
0.000.00%
Last trade - 00:00- $2.62m
- $35.61m
- $1.78m
Gamida rises on FDA approval for blood cancer therapy
US approves Gamida's therapy to reduce infection risk in cancer patients (updated)
US FDA approves Gamida's blood cancer therapy
U.S. STOCKS ON THE MOVE-Energy firms, crypto stocks, Walt Disney
U.S. STOCKS ON THE MOVE-Cyclerion, banks, Jounce Therapeutics
Brief: Gamida Cell Reports Full Year 2022 Financial Results
Cancer therapy developer Gamida falls on restructuring, job cut plans
Gamida Cell Ltd reports results for the quarter ended in December - Earnings Summary
Brief: Gamida Cell Plans To Downsize Its Current Workforce By Approximately 17% By End Of Q2 Of 2023
Gamida Cell Ltd expected to post a loss of 25 cents a share - Earnings Preview
Brief: Gamida Cell Announces Changes To Board Of Directors
Brief: Gamida Cell To Cancel Special Meeting Of Shareholders
Brief: Gamida Cell Enters Into Settlement With Lonza
Brief: Gamida Cell Ltd Files For Offering Of Up To 14.9 Mln Ordinary Shares - SEC Filing
Brief: Gamida Cell Announces Closing Of $25 Million Financing With Highbridge
U.S. STOCKS ON THE MOVE-Caterpillar, Coinbase, WW International
U.S. STOCKS ON THE MOVE-Best Buy, Warner Music, Abercrombie & Fitch
U.S. STOCKS ON THE MOVE-Energy firms, gold miners, Analog Devices
U.S. STOCKS ON THE MOVE-Obseva, Walgreens, Zoom